133605-55-7 ((L-Valine,glycyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-)

L-Valine,glycyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-;2-[[1-[2-[[2-[[2-[[2-[(2-aminoacetyl)amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbuta;ANGIOTENSIN III ANTIPEPTIDE;GLY-VAL-TYR-VAL-HIS-PRO-VAL;2-({1-[2-(2-{2-[2-(2-aminoacetamido)-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido}-3-methylbutanamido)-3-(3H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl}formamido)-3-methylbutanoic acid;Glycylvalyltyrosylvalylhistidylprolylvaline;DTXSID70657525;2-[[1-[2-[[2-[[2-[[2-[(2-aminoacetyl)amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoic acid;133605-55-7;

WWDNAGBKUMGNDQ-UHFFFAOYSA-N

1S/C37H55N9O9/c1-19(2)29(43-28(48)16-38)34(51)41-25(14-22-9-11-24(47)12-10-22)32(49)44-30(20(3)4)35(52)42-26(15-23-17-39-18-40-23)36(53)46-13-7-8-27(46)33(50)45-31(21(5)6)37(54)55/h9-12,17-21,25-27,29-31,47H,7-8,13-16,38H2,1-6H3,(H,39,40)(H,41,51)(H,42,52)(H,43,48)(H,44,49)(H,45,50)(H,54,55)

O=C(C(CC1=CN=CN1)NC(C(C(C)C)NC(C(CC1C=CC(=CC=1)O)NC(C(C(C)C)NC(CN)=O)=O)=O)=O)N1CCCC1C(NC(C(=O)O)C(C)C)=O